Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCM1K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,025
Award facts
- Contract value 100% obligated
- $11,025.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 3, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml units) with a ceiling value of $11,025.06. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to be completed by November 4, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has established a significant portfolio of federal contract awards with the Defense Logistics Agency's Medical Supply Chain, supplying a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Dupixent delivery order represents a specialized pharmaceutical procurement, with Dupixent being a widely used biologic medication for treating moderate-to-severe atopic dermatitis and other inflammatory conditions, fulfilling the company's role in delivering advanced therapeutic medications to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FCM1K?
SPE2DR26FCM1K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FCM1K worth?
The government has obligated $11,025 on SPE2DR26FCM1K.
Is contract SPE2DR26FCM1K an order under another contract?
Yes. SPE2DR26FCM1K is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCM1K competed?
The extent of competition for SPE2DR26FCM1K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award